SomnoMed Limited (ASX:SOM)
Australia flag Australia · Delayed Price · Currency is AUD
0.7850
+0.0100 (1.29%)
Aug 6, 2025, 3:02 PM AEST

SomnoMed Company Description

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe.

It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea.

The company also offers SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient’s upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances.

In addition, it provides Sunrise, a bio-signal to diagnose sleep apnea. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.

SomnoMed Limited
CountryAustralia
Founded1987
IndustryMedical Devices
SectorHealthcare
Employees300

Contact Details

Address:
20 Clarke Street
Crows Nest, 2065
Australia
Phone61 2 9467 0400
Websitesomnomed.com

Stock Details

Ticker SymbolSOM
ExchangeAustralian Securities Exchange
Fiscal YearJuly - June
Reporting CurrencyAUD
ISIN NumberAU000000SOM1
SIC Code3843

Key Executives

NamePosition
Karen Borg B.A.Co-Chief Executive Officer and Executive Director
Amrita Blickstead BME, M.B.A.Co-Chief Executive Officer and Executive Director
Mark HardingSenior Vice President of Global Marketing
Matthew ConlonExecutive Vice President of Sales and Marketing - North America
Marco Van KleefVice President of Marketing and Sales - Europe
Ye-Fei GuoChief Financial Officer
Terence A. Flitcroft B.Com., B.Comm., C.A., SF FINCompany Secretary
Christopher BedfordVice President of Global Production and Product Development